Pambio-noranco, Switzerland

Annalida Di Nola

This inventor holds 1 USPTO granted patent, plus 1 CIPO patent. Top assignee: Altergon Sa. Active years: 2016.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Annalida Di Nola. Retrieved from https://idiyas.com/inventor/annalida-di-nola

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank


Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2016

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Annalida Di Nola

Introduction

Annalida Di Nola is a notable inventor based in Pambio-Noranco, Switzerland. He has made significant contributions to the field of biochemistry, particularly in the production of chondroitin sulphate. His innovative work has led to the development of a unique process that enhances the properties of this important polysaccharide.

Latest Patents

Annalida holds 1 patent for his groundbreaking work. The patent discloses a process for the production of chondroitin sulphate, wherein N-acetyl-galactosamine residues sulphated at the 4- or 6-positions are present on the same polysaccharide chain. This innovation has potential applications in various medical and pharmaceutical fields.

Career Highlights

Annalida is currently associated with Altergon SA, a company that focuses on biopharmaceuticals. His role at Altergon has allowed him to further his research and development efforts in the area of glycosaminoglycans, contributing to advancements in therapeutic applications.

Collaborations

Annalida has worked alongside esteemed colleagues such as Emiliano Bedini and Mario De Rosa. Their collaborative efforts have fostered a productive research environment, leading to significant advancements in their respective fields.

Conclusion

Annalida Di Nola's contributions to the field of biochemistry, particularly through his innovative patent, highlight his role as a key inventor in the industry. His work continues to influence the development of important biopharmaceutical products.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…